Used as a key intermediate in the synthesis of certain antiparasitic and antimicrobial agents, particularly in the development of nitroimidazole-class drugs. Its chiral epoxide structure allows for selective reactions in pharmaceutical manufacturing, enabling the production of enantiomerically pure compounds. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) targeting anaerobic bacteria and protozoan infections. The compound's reactivity supports conjugation in prodrug formulations, enhancing drug delivery and bioavailability.